-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Pharvaris, Raises Price Target to $42

Benzinga·04/07/2026 12:42:35
Listen to the news
Wedbush analyst Laura Chico maintains Pharvaris (NASDAQ:PHVS) with a Outperform and raises the price target from $41 to $42.